Search Results for: stem cells for ms

Reading the tea leaves as new FDA commish Gottlieb blogs on regenerative medicine

/ / 3 Comments
Dr.-Scott-Gottlieb

New FDA Commissioner Dr. Scott Gottlieb, M.D., has in the past touched on stem cells and regenerative medicine therapies in speeches or written comments prior to starting his tenure at the agency. Now that he is Commissioner, he is poised to have direct impact on our field rather quickly and potentially with major changes in […]

Reading the tea leaves as new FDA commish Gottlieb blogs on regenerative medicine Read More »

Hans Keirstead interview on his congressional run, how you can help

/ / 3 Comments
Hans-Keirstead-Roman-Reed-1-1

Hans Keirstead is one of the top stem cell scientists in the world who has been doing cutting edge research including on using stem cells to reverse paralysis where he teamed up with super patient advocate Roman Reed (see the two pictured at right), but now he is also running for Congress. How cool is that?

Hans Keirstead interview on his congressional run, how you can help Read More »

Highlights of ISSCR2017 – A Biomedical Engineer’s Perspective

/
Agnes-Soos

ISSCR meeting review By Agnes Soos Amid the hustle and bustle of downtown Boston, nearly four thousand researchers and exhibitors gathered for the 15th Annual ISSCR Meeting. With presentations from over thirty plenary lectures, and dozens of others featured in concurrent sessions and the daily Innovation Showcases, there definitely was no shortage of exciting research

Highlights of ISSCR2017 – A Biomedical Engineer’s Perspective Read More »

Journal club review of new CRISPR ‘lots of off-target activity’ mouse paper

/ / 3 Comments
CRISPR-mutations-Figure-1a

A new, brief study in mice from the Vinit Mahajan lab argues CRISPR can have very large numbers of off-target sites. Their paper is entitled “Unexpected mutations after CRISPR–Cas9 editing in vivo” and was published in Nature Methods.This work has garnered a lot of attention in the media. Let’s take a journal club review kind of approach

Journal club review of new CRISPR ‘lots of off-target activity’ mouse paper Read More »

President Mills Leaving, CIRM Needs New Leader to Navigate Future Challenges

/
Randy-Mills

CIRM announced today that its President and CEO, Randy Mills, is soon leaving for a new job as President of the National Marrow Donor Program/Be The Match in Minnesota. Update: Dr. Maria Millan, the CIRM Vice President of Therapeutics, will be its leader starting July 1 until a new leader is chosen. For this kind of

President Mills Leaving, CIRM Needs New Leader to Navigate Future Challenges Read More »

Why UC Berkeley deserves the main CRISPR patent

/ / 7 Comments
statment_gene_editing-tech

Some months back a USPTO court issued a ruling that most interpreted as meaning the Broad Institute had won the so-called ‘CRISPR patent battle’ in the U.S. and that UC Berkeley, Jennifer Doudna, and Emmanuelle Charpentier had lost. Now this week Berkeley has appealed that ruling. It seems the odds are against Berkeley prevailing in its appeal, but frankly

Why UC Berkeley deserves the main CRISPR patent Read More »

Synthetic embryo or embryo model tech reported in Science: how big is this?

/ / 1 Comment
progression-for-cgs_bs-1-e1488559282646

Can you make a synthetic embryo, also called an embryo model? Developmental biologist Magdalena Zernicka-Goetz has long been on the trail of this seemingly almost uncatchable quarry. With her team’s publication in Science today they took a big step forward on this path even if some major hurdles remain. You can see her discussion of

Synthetic embryo or embryo model tech reported in Science: how big is this? Read More »